Oral health-related quality of life is more strongly correlated with mental health than with oral health in relapsing-remitting multiple sclerosis
- PMID: 36301199
- PMCID: PMC10100121
- DOI: 10.1111/joor.13387
Oral health-related quality of life is more strongly correlated with mental health than with oral health in relapsing-remitting multiple sclerosis
Abstract
Background: Multiple sclerosis (MS) is a leading cause of neurological disability in young and middle-aged populations, associated with substantial burden of illness. Because a growing literature now shows that this burden extends to poorer oral health, oral health-related quality of life (OHRQoL) may be reduced as well.
Objectives: To test whether people with relapsing-remitting MS (RRMS) have poorer OHRQoL than demographically matched controls, and to establish which variables are associated with worse OHRQoL.
Materials and methods: In total, 64 people with RRMS and 69 demographically matched controls participated. Both groups completed the Oral Health Impact Profile (OHIP-14), a validated measure of OHRQoL, as well as an objective oral health examination performed by a qualified dentist, a measure of dental-related functionality and a measure of mental health.
Results: OHRQoL was significantly poorer in the RRMS relative to the control group. However, although poorer OHRQoL in the RRMS group was moderately associated with objectively assessed oral health (r = .30), it was more strongly associated with mental health (r = .61). For the control group, the reverse pattern of association was evident, with OHRQoL more strongly associated with oral health (r = .48) relative to mental health (r = .20).
Conclusion: People with RRMS report poorer OHRQoL than demographically matched controls, but these appraisals are more strongly linked to mental health than to objective oral health indicators.
Keywords: multiple sclerosis; neurological disorder; oral health; oral health-related quality of life; well-being.
© 2022 The Authors. Journal of Oral Rehabilitation published by John Wiley & Sons Ltd.
Conflict of interest statement
None.
Similar articles
-
Cognitive function and oral health in relapsing-remitting multiple sclerosis.Clin Oral Investig. 2022 Mar;26(3):2899-2907. doi: 10.1007/s00784-021-04272-1. Epub 2021 Nov 13. Clin Oral Investig. 2022. PMID: 34773142
-
The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life.Br J Clin Psychol. 2016 Nov;55(4):371-386. doi: 10.1111/bjc.12106. Epub 2016 Jan 25. Br J Clin Psychol. 2016. PMID: 26806805
-
Burden of relapsing-remitting multiple sclerosis on workers in the US: a cross-sectional analysis of survey data.BMC Neurol. 2019 Oct 28;19(1):258. doi: 10.1186/s12883-019-1495-z. BMC Neurol. 2019. PMID: 31660897 Free PMC article.
-
Secondary progressive multiple sclerosis: a systematic review of costs and health state utilities.Curr Med Res Opin. 2021 Jun;37(6):995-1004. doi: 10.1080/03007995.2021.1904860. Epub 2021 Apr 6. Curr Med Res Opin. 2021. PMID: 33733976
-
Four-dimensional oral health-related quality of life impact in children: A systematic review.J Oral Rehabil. 2021 Mar;48(3):293-304. doi: 10.1111/joor.13066. Epub 2020 Aug 19. J Oral Rehabil. 2021. PMID: 32757443 Free PMC article.
Cited by
-
Chronic periodontitis in a patient with multiple sclerosis-A case report.Clin Case Rep. 2024 Aug 6;12(8):e9261. doi: 10.1002/ccr3.9261. eCollection 2024 Aug. Clin Case Rep. 2024. PMID: 39114839 Free PMC article.
-
A Systematic Literature Review on Inflammatory Markers in the Saliva of Patients with Multiple Sclerosis: A Cause or a Consequence of Periodontal Diseases.Medicina (Kaunas). 2024 May 24;60(6):859. doi: 10.3390/medicina60060859. Medicina (Kaunas). 2024. PMID: 38929476 Free PMC article.
References
-
- Manchery N, Henry JD, Nangle MR. A systematic review of oral health in people with multiple sclerosis. Community Dent Oral Epidemiol. 2020;48(2):89‐100. - PubMed
-
- Cockburn N, Pateman K, Taing MW, Pradhan A, Ford PJ. Managing the oral side‐effects of medications used to treat multiple sclerosis. Aust Dent J. 2017;62(3):331‐336. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical